1 Article by Deepak Cyril D'Souza
Addressing blinding in classic psychedelic studies with innovative active placebos.
The international journal of neuropsychopharmacology – April 04, 2025
Summary
Classic psychedelics show great potential for treating neuropsychiatric disorders, but weak blinding in studies can skew results. This review highlights the need for innovative active placebos that mimic drug effects without therapeutic benefits. By improving control conditions, researchers can better assess the true efficacy and safety of psychedelics.
Abstract
Classic psychedelics show promise as a treatment for various neuropsychiatric disorders. However, weak blinding integrity in trials has been argued...